Not all individuals with CLL need therapy. Even with all the latest developments, the iwCLL nevertheless recommends watchful observation for patients with asymptomatic sickness.86 This advice is predicated on a minimum of two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR